Ron Bentsur - Chairman & CEO, Director, 10%+ Owner at Nuvectis Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chairman & CEO, Director, 10%+ Owner
Issuer Symbol
NVCT on Nasdaq
All Insider Reports
All Insider Reports

Ron Bentsur - trading volume in the past year for Nuvectis Pharma, Inc.

Holdings reported by Ron Bentsur for Nuvectis Pharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,675,924 $27,752,858 $7.55 06 Jan 2026 Direct

Transactions reported by Ron Bentsur for Nuvectis Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.